touchPODCAST
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005, we make positive changes to clinical practice with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates. It is home to touchONCOLOGY, touchENDOCRINOLOGY, touchOPHTHALMOLOGY, touchNEUROLOGY, touchCARDIOLOGY, touchINFECTIOUSDISEASES, touchIMMUNOLOGY, touchRESPIRATORY, touchHAEMATOLOGY, and touchDERMATOLOGY. This information is intended for use by licensed Healthcare Professionals (HCPs) and should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
From first-line to next-gen: Tailoring hormonal contraception to the individual patient
touchEXPERT FOCUS for touchENDOCRINOLOGY
Listen to a series of interviews with Dr. Sheila Mody who will provide her expert insights into oral and nonoral hormonal contraceptive options, guidance on correct use of transdermal patches and strategies to support shared decision-making in selection of hormonal contraceptives.
The expert:
Dr. Sheila Mody based in San Diego, CA, USA
This touchPODCAST i
Glycogen storage disease type Ia: From pathophysiology to multidisciplinary management
touchEXPERT FOCUS for touchENDOCRINOLOGY and touchHEPATOLOGY
Hear from our expert faculty as they share insights into the pathophysiology, treatment, and multidisciplinary management of glycogen storage disease type Ia (GSDIa). This series of short interviews explores the clinical manifestations of the disorder and highlights how day-to-day standard of care requires a coordinated, multidisciplinar
Operationalizing the cardiac amyloidosis MDT
Listen to our expert faculty discuss multidisciplinary care for cardiac amyloidosis, including referral pathways, coordinated treatment decisions and collaboration between specialist centers and local care teams. They also explore monitoring and follow-up for cardiac amyloidosis.
The multidisciplinary team:
Cardiologist – Dr. Christian Nitsche, Medical University of Vienna, Vienna, Austria
Hema
Integrating emerging AL therapies into real‑world MDT decisions
Listen to our expert faculty discuss multidisciplinary treatment decisions for amyloid light-chain amyloidosis (AL), including cardiac and renal care, treatment tolerability and frailty. They also explore emerging fibril-directed therapies and their potential role alongside plasma-cell–directed treatment, informed by clinical evidence and local approval.
The multidisciplinary team:
Hematologist –
Building a shared AL vs. ATTR diagnostic pathway
Listen to our expert faculty explore a shared diagnostic pathway for cardiac amyloidosis, including clinical and imaging red flags, monoclonal-protein testing, and the role of biopsy and amyloid typing. They also explore multidisciplinary collaboration and when to prioritize ruling out amyloid light-chain amyloidosis (AL).
The multidisciplinary team:
Cardiologist – Dr. Christian Nitsche, Medica
touchEXPERT FOCUS - Integrating EGFR-directed strategies into early-stage NSCLC care
touchEXPERT FOCUS for touchONCOLOGY & touchRESPIRATORY
Listen to Dr. James CH Yang discuss the integration of EGFR-directed strategies into early-stage NSCLC care, covering patient selection for perioperative and adjuvant systemic therapy, optimizing treatment duration and interpreting recurrence risk, and proactive management of treatment-related adverse events to support sustained, curative-
Expert insights on optimizing early discharge and home-based diuresis in HF
touchEXPERT FOCUS for touchCARDIO
Listen to Dr. Anuradha Lala-Trindade discuss the burden of heart failure hospitalization, why inpatient intravenous diuresis remains the conventional approach to worsening heart failure, and how outpatient and home-based decongestion strategies, supported by appropriate patient selection, monitoring and follow-up, can help overcome barriers to discharge and suppor
Raising awareness of Lennox–Gastaut syndrome: Recognition, polypharmacy, and non-seizure symptoms
touchPANEL DISCUSSION for touchNEUROLOGY
Hear from three experts as they share practical insights into recognizing and diagnosing Lennox–Gastaut syndrome across the lifespan, navigating the complexities of polytherapy, and addressing the cognitive, behavioral, functional, and quality of life challenges that extend beyond seizure control.
The experts:
Dr. Elaine Wirrell —Mayo Clinic, Rochester, MN
Stargardt disease and the role of vitamin A: Disease pathogenesis and the promise of oral therapies
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to an interview with Dr. Christine Kay on the role of vitamin A in the retina, how vitamin A processing is disrupted in Stargardt disease, and the mechanism of action, emerging clinical evidence, and key safety considerations for emerging oral therapies.
The expert:
Dr. Christine Kay, Vitreoretinal Associates, Gainesville, FL, USA
This activity is
Management of NF1-related PNs: Approaches for delivering state-of-the-art care
touchIN CONVERSATION for touchNEUROLOGY and touchONCOLOGY
Management of neurofibromatosis type 1 (NF1)–associated plexiform neurofibromas in adults requires individualized decisions that account for symptoms, function, resectability and patient goals. Listen to NF1 experts Prof. Allan Belzberg, a neurosurgeon, and Dr. Angela Hirbe, an oncologist, as they discuss targeted therapy, adverse-effect mo
touchMDT - Coordinated care and evolving therapies: Implications for future pathways
Dr. Melinda Gooderham, Prof. Dr. Falk Bechara, and Dr. Daniel Stein discuss how evolving therapies are reshaping HS management and multidisciplinary care, with patient perspectives highlighting the impact of coordinated care and effective disease control.
The multidisciplinary team
Dr. Melinda Gooderham - SKiN Centre for Dermatology, Peterborough, Ontario, Canada
Prof. Dr. Falk Bechara - Ruhr Uni
touchMDT - Perineal and genital disease: Medical–surgical decision-making
Dr. Melinda Gooderham, Prof. Dr. Falk Bechara, and Dr. Daniel Stein discuss the medical and surgical decision-making challenges in perineal and genital HS, including common diagnostic pitfalls, how to integrate medical and surgical treatment, and the unique role of urology in managing complex disease.
The multidisciplinary team
Dr. Melinda Gooderham - SKiN Centre for Dermatology, Peterborough, O
touchMDT - Women’s health and HS: Vulvar disease, hormones and pregnancy
Dr. Melinda Gooderham and Dr. Jillian Kerry discuss the unique challenges of hidradenitis suppurativa in women, including vulvar disease, hormonal influences, pregnancy, and the importance of collaboration between dermatology and obstetrics and gynecology.
The multidisciplinary team
Dr. Melinda Gooderham - SKiN Centre for Dermatology, Peterborough, Ontario, Canada
Dr. Jillian Kerry - University o
touchMDT - Early recognition and referral: Capturing the window of opportunity
Dr. Melinda Gooderham and Prof. Dr. Falk Bechara discuss opportunities for earlier recognition and referral of hidradenitis suppurativa, including key clinical clues, referral pathways, and the impact of diagnostic delay. A patient perspective highlights the importance of timely diagnosis and coordinated care.
The multidisciplinary team
Dr. Melinda Gooderham - SKiN Centre for Dermatology, Peterbo
Empowering choice in HIV care: Moving beyond daily pills to person‐centered ART strategies
touchEXPERT FOCUS for touchINFECTIOUS DISEASES
Listen to a series of short interviews with three leading experts discussing preference-sensitive care for people living with HIV. Faculty consider the evolving landscape of simplified ART options, including long-acting injectable regimens, and provide practical strategies to align treatment choices with individual goals and preferences. They also dis
Recognizing MOGAD: Defining a distinct demyelinating disease
touchEXPERT FOCUS for touchNEUROLOGY, touchIMMUNOLOGY, touchOPHTHALMOLOGY
Dr. Eoin Flanagan shares his expert insights on myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and how to distinguish it from other demyelinating diseases like multiple sclerosis (MS) and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-positive NMOSD). As part of the int
Systemic mastocytosis: Making the right decisions at the right time (video 3)
touchMDT for touchIMMUNOLOGY, touchHEMATOLOGY, touchDERMATOLOGY, and touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss the diagnosis, classification, and management of patients with systemic mastocytosis. They provide their key insights on effectively recognizing systemic mastocytosis, integrating key classification criteria from the ICC and WHO, and how multidisciplinary c
Systemic mastocytosis: Making the right decisions at the right time (video 2)
touchMDT for touchIMMUNOLOGY, touchHEMATOLOGY, touchDERMATOLOGY, and touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss the diagnosis, classification, and management of patients with systemic mastocytosis. They provide their key insights on effectively recognizing systemic mastocytosis, integrating key classification criteria from the ICC and WHO, and how multidisciplinary c
Systemic mastocytosis: Making the right decisions at the right time (video 1)
touchMDT for touchIMMUNOLOGY, touchHEMATOLOGY, touchDERMATOLOGY, and touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss the diagnosis, classification, and management of patients with systemic mastocytosis. They provide their key insights on effectively recognizing systemic mastocytosis, integrating key classification criteria from the ICC and WHO, and how multidisciplinary c
Immunotherapy in R/M NPC: Interpreting the evidence and individualizing care
touchEXPERT FOCUS for touchONCOLOGY
Listen to an interview with Dr. Deborah Wong as she shares her expert insights on the current evidence and latest guidelines for immune checkpoint inhibitor (ICIs) use in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC). She also discusses how patient- and disease-specific factors can inform individualized treatment decisions.
The expert:
Dr. Deborah Wong
Chronic and/or recurrent postoperative intraocular inflammation: Improving diagnosis, classification and management
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of short interviews with three leading experts discussing chronic and/or recurrent postoperative intraocular inflammation. The faculty explore how to identify patients with persistent disease, differentiate infectious, mechanical, and non-infectious etiologies, and use multimodal imaging to evaluate underlying causes and posterior segment
Advancing the management of HER2-altered NSCLC: Interpreting the latest clinical trial data
touchCONGRESS for touchONCOLOGY and touchRESPIRATORY
Listen to thoracic oncologist Dr. Julia Rotow (USA) review the latest HER2-targeted therapy data for NSCLC from the 2026 ASCO Annual Meeting. Alongside Prof. David Planchard (France) and Dr. Misako Nagasaka (USA), they discuss these findings in the context of evidence presented at recent international congresses and their clinical implications
Where we are now in PDAC care: Clinical insights, emerging biomarkers and evolving therapeutic strategies
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss how biomarker-driven insights and emerging therapies are shaping treatment decisions in PDAC. They cover early testing strategies, novel targeted and immunologic therapies, and evidence-based treatment sequencing across the disease continuum.
The experts:
Dr. Allyson Ocean - Weill Cornell Medicine, New York, NY,
Reimagining Alzheimer’s care: Harnessing subcutaneous therapies and early diagnostic innovation to transform patient lives
touchPANEL DISCUSSION for touchNEUROLOGY
Listen to three leading experts discussing the recent advances in timely, biomarker-guided diagnosis and how current and emerging intravenous and subcutaneous disease-modifying therapies may impact clinical practice in the future and enable treatment personalization based on the underlying pathology of Alzheimer’s disease
The experts
Dr Soo Borson, Keck US
Building confidence in geographic atrophy care: From diagnosis to dialogue
touchIN CONVERSATION for touchOPHTHALMOLOGY
As treatment options for geographic atrophy continue to evolve, clinicians face new opportunities and challenges in diagnosis, treatment planning, and patient engagement. Join retina specialists Dr. Samuel Minaker and Dr. Priya Vakharia for a peer-to-peer discussion on geographic atrophy care, covering the patient journey from diagnosis to effective pat
Beyond ATTR in Japan: Accurate diagnosis of cardiac AL in the TTR stabilizer era (in Japanese)
touchEXPERT FOCUS for touchHEMATOLOGY, touchCARDIO and touchNEPHROLOGY
Listen to a series of interviews with Dr. Toru Kubo as he shares his expert insights into real-world diagnostic pitfalls in cardiac amyloid light-chain amyloidosis (AL), stepwise application of the Japanese Circulation Society (JCS) diagnostic algorithm to achieve an accurate diagnosis of cardiac AL, and timely engagement of h
Targeting pathogenic mechanisms in gMG: From complement- and FcRn-directed therapies to B- and T-cell-targeted approaches
touchTALKS for touchNEUROLOGY
Listen to an autoimmune neuromuscular disease expert review the unmet needs for patients with generalized myasthenia gravis and explain how emerging targeted therapies address underlying disease mechanisms to improve patient outcomes.
The expert
Dr. Richard Nowak, Yale School of Medicine, New Haven, CT, USA
This touchPODCAST is for healthcare professionals outside o
The art and science of presbyopia-correcting intraocular lens selection: From preoperative planning to patient satisfaction
touchCASES for touchOPHTHALMOLOGY
Listen to two experts as they discuss three cases illustrating the art and science of presbyopia-correcting intraocular lens (IOL) selection, from preoperative planning to patient satisfaction. They examine key decision points from preoperative assessment and clinical workup to presbyopia-correcting IOL selection in routine and complex cases.
The experts:
Dr. D
Unraveling the cortisol connection: Hard-to-control hypertension and hyperglycemia
touchTALKS for touchENDOCRINOLOGY
Listen to Dr. Richard Auchus, as he describes how hypercortisolism can lead to hyperglycemia and hypertension, and discusses how to recognize, screen, and manage hypercortisolism in at-risk patient populations.
The expert
Dr Richard J. Auchus, University of Michigan, Ann Arbor, MI, USA.
This touchPODCAST is for HCPs in the USA only.
This activity is funded by an
Reducing attrition and maximizing ADC impact in metastatic breast cancer
touchIN CONVERSATION for touchONCOLOGY
Identifying patients at risk of treatment attrition is an important part of treatment decision-making, as these patients may miss opportunities to receive subsequent treatments that could improve survival and quality of life. Listen to breast cancer experts consider the impact of treatment attrition in metastatic breast cancer and review evidence supporting t
The art of diagnosing CIDP: Strengthening diagnostic confidence
touchCASES for touchNEUROLOGY
Hear from two European experts as they discuss how to strengthen diagnostic confidence in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Through three patient cases, they address how to recognize and differentiate CIDP variants from other polyneuropathies and consider how key diagnostic criteria can be applied to reinforce diagnostic c
The key to ketoacidosis: Unlocking the potential for better DKA monitoring and detection
touchEXPERT FOCUS for touchENDOCRINOLOGY
Listen to a series of interviews with Dr. Eden Miller who will provide her expert insights into the recognition of typical and euglycemic diabetic ketoacidosis (DKA), the current and emerging ketone monitoring methods, including continuous ketone monitoring and the importance of optimizing patient and caregiver education to reduce preventable DKA events and
Optimizing outcomes in advanced endometrial carcinoma: Navigating guidelines, biomarker-driven immunotherapy and irAE management
touchCASES for touchONCOLOGY
Join two international experts as they walk through three real-world patient stories, showing how molecular testing shapes treatment choices in advanced endometrial cancer and how immune-related side effects can be recognized and managed in everyday practice.
The experts:
Dr Nicoletta Colombo, European Institute of Oncology, Milan, Italy
Dr Ilaria Colombo, Oncolo
Personalizing cataract surgery: From pre-operative precision to functional vision outcomes
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of short interviews with a leading expert in cataract surgery. Dr Filomena Ribeiro shares insights on the latest advances in pre-operative assessment, AI-enhanced IOL power calculation and functional depth-of-field (DOFi)-based lens selection, as well as emerging IOL materials and technologies. She also provides practical guidance on pati
Cracking the code of CIDP: Mastering diagnostic precision
touchCASES for touchNEUROLOGY
Listen to two US-based experts as they discuss how to improve diagnostic accuracy in the USA for patients with chronic inflammatory demyelinating polyneuropathy (CIDP). They will discuss three patient cases to illustrate how to recognize and differentiate CIDP variants from other polyneuropathies, and apply key diagnostic criteria to help strengthen a diagnosis.
The e
Looking beyond VEGF to target BRB dysfunction in DME: Novel approaches to prevent vision loss
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of interviews with Dr. Diana Do as she shares her expert insights into the epidemiology and quality‑of‑life burden of diabetic macular edema (DME) in the USA, outlines real‑world limitations of current anti‑VEGF–based management, and examines emerging therapies that specifically target blood–retinal barrier (BRB) dysfunction and aim to pr
Unlocking new potential: Rationale and evidence for dual EZH2/AR inhibition in mCRPC
touchTALKS for touchONCOLOGY
Listen to Dr Teresa Alonso-Gordoa, as she evaluates the latest data on dual EZH2/AR inhibition in mCRPC and explores how emerging evidence could influence clinical decision-making in the future.
The expert
Dr. Teresa Alonso-Gordoa - Hospital Universitario Ramón y Cajal, Madrid, Spain
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an
Integrating neurosensory pathway insights into modern dry eye management
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of short interviews with three leading experts discussing neural-targeted therapies for dry eye disease (DED). The faculty describe the neuronal control of tear secretion, explore the mechanisms of action and clinical findings with neuromodulatory/neurostimulatory therapies for DED, and discuss how to integrate these therapies into person
Computational pathology in NSCLC: From biomarker discovery to clinical integration
touchEXPERT FOCUS for touchONCOLOGY and touchRESPIRATORY
Listen to a series of short interviews with leading experts on computational pathology in NSCLC. The faculty, an oncologist, an oncologist-researcher and a pathologist, discuss the clinical value of computational pathology in NSCLC, review emerging tools and share practical insights on how these approaches can be applied in routine patient
Shaping the future of PDAC care: Scientific advances and therapeutic innovation
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the future of care for patients with pancreatic ductal adenocarcinoma, or PDAC. The faculty provide their insights on the current unmet needs, the evolving role of imaging, biomarker testing, and treatment strategies, and how these developments may impact clinical care.
The experts:
Dr Eileen O'Reilly - Memorial
Exploring all angles: Neuroprotective strategies beyond IOP in primary and steroid-induced open-angle glaucoma
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of interviews with Dr Maria-João Menéres who will provide her expert insights into the mechanisms of retinal ganglion cell (RGC) damage in both primary open-angle and secondary, steroid-induced glaucoma, and the importance of neuroprotection to mitigate the risk of glaucoma development or progression.
The expert:
Dr Maria-João Menéres,
Optimizing presbyopia-correcting IOL selection and patient expectations
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen as Prof. Sumit (Sam) Garg shares expert clinical insights on how AI-supported biometric analysis can increase refractive accuracy and support confident presbyopia-correcting IOL selection, including which patient and ocular characteristics are most likely to benefit from AI-based tools. He also outlines practical strategies for structuring preoperati
Advancing outcomes in CP-CML: Guideline-directed approaches to treatment decision-making, monitoring and toxicity management
touchPANEL DISCUSSION for touchHAEMATOLOGY and touchONCOLOGY
Listen to leading experts discuss guideline-directed strategies for mutational analysis and monitoring response when treating patients with chronic-phase chronic myeloid leukaemia with approved tyrosine kinase inhibitors.
The experts
Dr Jorge Cortes, Georgia Cancer Center, Augusta, GA, USA
Dr Elias Jabbour, MD Anderson Cancer Center,
The bare necessities of hyperphagia in Prader–Willi syndrome: Expert insights on recognition and management
touchEXPERT FOCUS for touchENDOCRINOLOGY
Listen to a series of short interviews with paediatric endocrinologist Dr Ashley Shoemaker as she discusses the clinical manifestations and pathophysiology of Prader–Willi syndrome (PWS), with a focus on hyperphagia by exploring the spectrum across the lifespan of PWS and shares best practices for managing PWS-related hyperphagia within a multidisciplinary
Targeting brain metastases in advanced NSCLC: The emerging impact of ADCs
touchPANEL DISCUSSION for touchONCOLOGY and touchRESPIRATORY
Listen to leading experts discuss the role of antibody–drug conjugates (ADCs) in NSCLC with brain metastases, including the latest clinical trial evidence, practical approaches to patient selection and treatment sequencing alongside local CNS therapies, and the evolving pipeline of investigational ADCs.
The expert(s)
Dr Lyudmila Bazhe
Evolving paradigms in PNH management: Interpreting the latest data
touchPANEL DISCUSSION for touchHAEMATOLOGY and touchONCOLOGY
Listen to a panel of leading experts as they explore the latest advances in PNH pathophysiology, diagnostic approaches and therapeutic strategies, including data from ASH 2025, with practical insights for contemporary clinical practice.
The experts:
Prof. Bruno Fattizzo, Università degli Studi di Milano, Milan, Italy
Dr Austin Kulasekar
Diagnosis, multidisciplinary monitoring and individualized management in LOPD
touchCASES for touchNEUROLOGY, touchCARDIO, touchENDOCRINOLOGY and touchRESPIRATORY
Listen to two experts as they discuss three cases illustrating the heterogeneous, multisystem nature of late-onset Pompe disease (LOPD). They examine key decision points from recognizing early clinical clues and confirming diagnosis to optimizing enzyme replacement therapy (ERT), monitoring progression and coordina
Unlocking the possibilities of BCMA-directed therapies in RRMM: Latest perspectives from IMS and ASH 2025
touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY
Listen to multiple myeloma expert Dr Rakesh Popat review key data for BCMA-targeting agents in the treatment of relapsed/refractory multiple myeloma presented at the International Multiple Society (IMS) and American Society of Hematology (ASH) 2025 congresses. Dr Popat is then joined by fellow experts Dr Paula Rodríguez-Otero and Dr Roberto Mina
Overcoming EGFR-TKI resistance: Emerging therapies and biomarker strategies in NSCLC
touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY
Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms
In this module, Professors Jänne and Girard explore the challenges of resistance to EGFR-targeted therapies in non-small cell lung cancer. They discuss how mechanisms such as MET and HER2 amplification drive resistance to first-line osimertinib, review emerging
Evolving strategies in low-grade serous ovarian cancer: Applying the evidence to optimize patient care
touchEXPERT FOCUS for touchONCOLOGY
Listen to insights from Dr Kathleen Moore on the pathophysiology and molecular features of low-grade serous ovarian cancer (LGSOC) and how it differs from other ovarian cancers. She also discusses evidence-based treatment options and sequencing, as well as practical considerations relating to administration and side-effect management.
The expert:
Dr Kathleen Mo
Managing cytopenias: The path to transfusion independence for patients with myelofibrosis
touchIN CONVERSATION for touchHAEMATOLOGY
The presence of anaemia and/or thrombocytopenia complicates the management of patients with myelofibrosis (MF). Listen to expert haematologists consider the burden of cytopenias in patients with MF and discuss strategies to reduce transfusion dependence, improve splenomegaly and personalize treatment with JAK inhibitors.
The experts
Prof. Claire Harrison,
Innovations and advances in CML: Focus on navigating early-line options and maintaining quality of life
touchEXPERT FOCUS for touchHAEMATOLOGY and touchONCOLOGY
Listen to a series of short interviews with three leading experts who provide their insights into early-line management of chronic myeloid leukaemia and the impact on quality of life.
The experts:
Dr Delphine Rea, Hôpital Saint-Louis, Paris, France
Prof. Andreas Hochhaus, Jena University Hospital, Jena, Germany
Prof. Etab Atallah, Medical
Breakthroughs in treating NSCLC: Targeting KRAS
touchTALKS for touchONCOLOGY
Listen to Dr Christine Bestvina, as she evaluates the latest data on KRAS mutations in NSCLC and explores how emerging evidence for targeted therapies could influence clinical decision-making.
The expert
Dr Christine Bestvina, University of Chicago, Chicago, IL, USA
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical edu
HER2 in focus: Advancing treatment for biliary tract and gastroesophageal cancers
touchEXPERT FOCUS for touchONCOLOGY
Listen to a series of short interviews with four leading experts as they discuss the role of HER2 as a targetable biomarker in BTC and GEA. They examine the present treatment landscape for HER2-positive BTC and GEA and evaluate clinical implications of recent approvals and advances in current and emerging HER2-targeting therapies for HER2-positive BTC and GEA.
Delivering state-of-the-art care for GEP-NETs: Evidence-based strategies for PRRT
touchPANEL DISCUSSION for touchONCOLOGY and touchENDOCRINOLOGY
Listen to a panel of leading experts discuss the optimal management of gastroenteropancreatic neuroendocrine tumours (GEP-NETs), with a focus on peptide receptor radionuclide therapy (PRRT). The faculty provide their insights on the current state of the art, the evolving role of PRRT in GEP-NET treatment, and recent data with existing
Overcoming EGFR-TKI resistance: Emerging therapies and biomarker strategies in NSCLC
touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY
Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms
In this module, Professors Jänne and Girard explore the challenges of resistance to EGFR-targeted therapies in non-small cell lung cancer. They discuss how mechanisms such as MET and HER2 amplification drive resistance to first-line osimertinib, review emerging
Eyeing better outcomes in diabetic macular oedema: Clinical insights on the evolving role of corticosteroids
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of interviews with two medical retina specialists and a biomarker expert who will provide their insights into the pathophysiology of diabetic macular oedema (DMO), including the inflammatory mechanisms of disease and how they may impact treatment. The faculty will also consider the clinical utility of optical coherence tomography (OCT) im
Diagnosis and treatment of patients with Lennox–Gastaut syndrome
touchPANEL DISCUSSION for touchNEUROLOGY
Listen to a panel of experts in epilepsy as they discuss how to promptly and accurately diagnose and manage Lennox–Gastaut syndrome (LGS). Moderated by a leading European expert, this episode brings together faculty from the Gulf region and Japan, as they explore diagnostic approaches in their regions, before sharing their unique regional perspectives and r
Updates in hypertrophic cardiomyopathy care: Bridging the current treatment gaps with emerging novel therapies
touchEXPERT FOCUS for touchCARDIO
Listen to short interviews with two expert cardiologists discussing the role of current and emerging therapeutic classes that aim to address the unmet needs of patients with hypertrophic cardiomyopathy. The faculty will review current therapeutic approaches for managing obstructive versus nonobstructive hypertrophic cardiomyopathy to highlight existing gaps in pat
Overcoming EGFR-TKI resistance: Emerging therapies and biomarker strategies in NSCLC
Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms
touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY
In this module, Professors Jänne and Girard explore the challenges of resistance to EGFR-targeted therapies in non-small cell lung cancer. They discuss how mechanisms such as MET and HER2 amplification drive resistance to first-line osimertinib, review emerging
Staying ahead of the curve in HNSCC care: Refining the role of immunotherapy across disease stages
touchEXPERT FOCUS for touchONCOLOGY
Listen to insights from Prof. Jean-Pascal Machiels on optimizing the use of immunotherapy in patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) and the potential future role of immunotherapy in resectable locally advanced HNSCC.
The expert:
Prof. Jean-Pascal Machiels, Cliniques universitaires Saint-Luc, Brussels, Belgium
This to
FCS unmasked: Closing gaps in diagnosis, treatment and patient support
touchIN CONVERSATION for touchCARDIOLOGY and touchENDOCRINOLOGY
Listen to two experts as they discuss the diagnosis, treatment and how to support patients with FCS. They cover how to recognize key clinical signs and symptoms, strategies to help manage symptoms, reduce triglyceride levels and prevent complications. They also share key insights from their experience with novel targeted therapies fo
Achieving effective lifespan care in sickle cell disease: From recognizing the burden to novel therapeutics
touchEXPERT FOCUS for touchHAEMATOLOGY
Prof. Lucia de Franceschi, a leading expert in sickle cell disease, examines the clinical manifestations and burden of the condition, reviews current and emerging treatments and offers guidance on comprehensive lifespan care that addresses complications, quality of life, and disparities, while highlighting the essential role of multidisciplinary support.
The
Bridging diagnostic and therapeutic gaps in Fabry disease management
touchEXPERT FOCUS for touchENDOCRINOLOGY, touchCARDIO and touchNEUROLOGY
Listen to a series of short expert interviews on timely diagnosis and individualized care for Fabry disease, using genetic and clinical insights. Our faculty discuss strategies to reduce diagnostic delays, identify clinically relevant genetic variants and tailor treatment based on each patient's genotype–phenotype correlatio
Applying patient and disease characteristics to guide R/M NPC treatment
touchCASES for touchONCOLOGY
Listen to three experts as they discuss how patient and disease characteristics may inform treatment selection in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC). They will discuss the cases of three patients which will cover first-line and second-line treatments as well as key considerations for their treatment plans in their patients' cases.
The experts:
Dr
Therapeutic advances in RRMM: What is the latest on practical application of BCMA-directed therapies?
touchEXPERT FOCUS for touchHAEMATOLOGY and touchONCOLOGY
Listen to a series of short expert interviews on the role of B-cell maturation antigen (BCMA)-directed therapies in relapsed/refractory multiple myeloma (RRMM). The faculty discuss patient selection, treatment tailoring and strategies to manage side effects, providing practical guidance for integrating BCMA-targeting approaches into care.
Th
Phacoemulsification in cataract surgery: Evolving options to optimize refractive outcomes
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of short interviews with leading experts on phacoemulsification in cataract surgery. The faculty discuss optimizing fluidics and ultrasound energy, ophthalmic viscosurgical device selection, and integrating technological advances in phacoemulsification into clinical practice.
The experts:
Dr Ike K Ahmed, Prism Eye Institute, Toronto, ON,
Stargardt disease: Improving awareness, diagnosis and patient support
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of interviews with Prof. Elias Traboulsi on the clinical presentation, diagnosis and management of patients with Stargardt disease. Prof. Traboulsi shares key clinical characteristics and retinal imaging results indicative of Stargardt disease, discusses the right tools to use to accurately and promptly diagnose the condition, and reviews
Mastering DKA management: From pathophysiology to prevention and ketone monitoring strategies
touchTALKS for touchENDOCRINOLOGY
Listen to Prof. Jennifer Sherr, as she discusses key updates on the prevention and management of DKA. The discussion covers the clinical features and aetiology of DKA, its impact on people living with diabetes, the underlying metabolic pathways, risk factors, common triggers, and the pillars of management. Prof. Sherr also explores strategies for prevention and
A case-based discussion on PAH: Optimizing early detection, risk stratification and treatment decision-making
touchCASES for touchRESPIRATORY and touchCARDIO
This touchCASES activity presents expert-led discussions exploring three clinical cases of pulmonary arterial hypertension (PAH). Through these detailed cases, the expert faculty examine a range of clinical presentations and highlight critical decision points across the patient journey, from initial diagnosis and risk stratification to treatment init
Continuous glucose monitoring for cardiovascular risk reduction: The next frontier in preventive care
touchEXPERT FOCUS for touchCARDIO and touchENDOCRINOLOGY
Listen to two experts discuss how continuous glucose monitoring (CGM) can help identify and manage cardiovascular risk in people with or without diabetes. They explore the role of glycaemic variability, the limitations of conventional glucose metrics, and the added value of CGM, including recent advances and patient education to support effe
HER2 as a targetable biomarker in gastrointestinal oncology
touchEXPERT FOCUS for touchONCOLOGY
Listen to a series of short interviews with three leading experts as they discuss the use of HER2 as a targetable biomarker in gastrointestinal oncology. The faculty cover the clinical significance of HER2 alterations, best practices for biomarker testing, key clinical trial data on efficacy and safety, and the role of HER2-targeted therapies in both common and
Navigating the evolving role of immunotherapy in advanced endometrial carcinoma
touchPANEL DISCUSSION for touchONCOLOGY
Listen to three leading international experts in gynaecological oncology as they discuss how immunotherapy is transforming the treatment of advanced endometrial carcinoma. The faculty explore how the latest data are shaping first-line treatment decisions, how to personalize therapy using biomarkers and molecular classification, and how to manage immune-relat
Focus on treatment advances for ATTRv: A heterogeneous, highly debilitating and ultimately fatal disease
touchEXPERT FOCUS for touchNEUROLOGY and touchCARDIO
Listen to Dr Chafic Karam share expert insights on diagnosing and managing ATTRv amyloidosis. In this short interview, he covers red-flag symptoms, diagnostic challenges and key strategies for differentiating ATTRv. He also discusses current treatment options, including TTR stabilisers and gene silencers, as well as emerging therapies aimed at i
Navigating the treatment of RRMM with BCMA-directed therapies: Updates from COMy, ASCO and EHA 2025
touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY
Listen to multiple myeloma expert Prof. Philippe Moreau review key data for BCMA-targeting agents in the treatment of relapsed/refractory multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy), American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) 2025 congresses. Prof. Moreau is
Advancing care for patients with infantile haemangiomas: Timing is key
touchEXPERT FOCUS for touchDERMATOLOGY
Listen to Prof. Ilona Frieden share expert insights on the clinical management of infantile haemangiomas, with a focus on timely referral and effective risk stratification. She also explores current and emerging treatment options and practical strategies to support families throughout a patient’s care journey.
The expert:
Prof. Ilona Frieden, University of
Incorporating ADCs into the treatment of mBC: Practical considerations for the community oncologist
touchIN CONVERSATION for touchONCOLOGY
Listen to two oncologists discuss the incorporation of antibody–drug conjugates (ADCs) into the treatment of metastatic breast cancer, tackling questions submitted by the oncology community. They discuss how treatment can be guided by biomarkers, give practical insights into creating a personalized care plan for patients, and share strategies for managing ADC
Multidisciplinary management of TNBC Integrating immunotherapies for early and metastatic disease
touchEXPERT FOCUS for touchONCOLOGY
Listen to a series of short interviews with three leading experts discussing the application of immunotherapy in triple-negative breast cancer (TNBC). The experts explore the latest data and guideline recommendations for immunotherapy in early-stage and metastatic TNBC, and how to maximize treatment benefits.
The experts:
Prof. Sherko Kümmel – Kliniken Essen-M
Applying immunotherapy in clinical practice for patients with early-stage NSCLC
touchEXPERT FOCUS for touchRESPIRATORY
Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation.
The expert
Prof. Jonathan Spicer, McGill University, Montreal
Applying immunotherapy in clinical practice for patients with early-stage NSCLC
touchEXPERT FOCUS for touchONCOLOGY
Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation.
The expert
Prof. Jonathan Spicer, McGill University, Montreal, C
